Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 45

Sort by

Sort Order Select

Journal Articles

Abstract 6366: A novel small molecule inhibitor of MAPK and PI3K ameliorates disease phenotypes in myelofibrosis

Christopher A. Bonham, Youngsoon Jang, Kevin Heist, Amanda Welton, Tanner Robison, Kathryn E. Luker, Gary D. Luker, Winston Y. Lee, Thomas L. Chenevert, Marcian Van Dort, Brian D. Ross

Cancer Res (2022) 82 (12_Supplement): 6366.

https://doi.org/10.1158/1538-7445.AM2022-6366

Published: 15 June 2022

View article titled, Abstract 6366: A novel small molecule inhibitor of MAPK and PI3K ameliorates disease phenotypes in myelofibrosis

Journal Articles

Abstract 3936: Orally bioavailable 'lymphatropic' kinase inhibitors

Brian D. Ross, Youngsoon Jang, Amanda Welton, Christopher A. Bonham, Kevin Heist, Lucas McDonald, Gary D. Luker, Thomas L. Chenevert, Marcian Van Dort

Cancer Res (2022) 82 (12_Supplement): 3936.

https://doi.org/10.1158/1538-7445.AM2022-3936

Published: 15 June 2022

View article titled, Abstract 3936: Orally bioavailable 'lymphatropic' kinase inhibitors

Journal Articles

Abstract 2073: Transcriptome profiles of cancer stem-like cells in patient-derived diffuse intrinsic pontine glioma (DIPG)

Stefanie Galbán, Carlos Espinoza, Karan Bedi, Uday B. Maachani, Mark M. Souweidane, Mats Ljungman, Marcian Van Dort, Brian D. Ross

Cancer Res (2018) 78 (13_Supplement): 2073.

https://doi.org/10.1158/1538-7445.AM2018-2073

Published: 01 July 2018

View article titled, Abstract 2073: Transcriptome profiles of cancer stem-like cells in patient-derived diffuse intrinsic pontine glioma (DIPG)

Journal Articles

Abstract 3875: Lymphatically directed MAPK/PI3K/mTOR inhibitor for treatment of cancer growth and metastasis

Stefanie Galbán, Carlos Espinoza, Kathryn E. Luker, Gary D. Luker, Marcian Van Dort, Brian D. Ross

Cancer Res (2018) 78 (13_Supplement): 3875.

https://doi.org/10.1158/1538-7445.AM2018-3875

Published: 01 July 2018

View article titled, Abstract 3875: Lymphatically directed MAPK/PI3K/mTOR inhibitor for treatment of cancer growth and metastasis

Journal Articles

Abstract 2061: Extended adjuvant temozolomide improves survival in a glioblastoma mouse model

Hanxiao Wang, Wajd Al-Holou, Kevin Heist, Craig J. Galbán, Ana C. deCarvalho, Tom Mikkelsen, Brian D. Ross, Alnawaz Rehemtulla

Cancer Res (2014) 74 (19_Supplement): 2061.

https://doi.org/10.1158/1538-7445.AM2014-2061

Published: 01 October 2014

View article titled, Abstract 2061: Extended adjuvant temozolomide improves survival in a glioblastoma mouse model

Journal Articles

Abstract 1137: Bub1 is a key regulator of TGF-β signaling

Shyam Nyati, Katrina Schinske-Sebolt, Sethuramasundaram Pitchiaya, Katerina Chekhovskiy, Areeb Chator, Nauman Chaudhry, Joseph Dosch, Marcian E. Van Dort, Sooryanarayana Varambally, Chandan Kumar-Sinha, Mukesh K. Nyati, Dipankar Ray, Nils G. Walter, Hongtao Yu, Brian D. Ross, Alnawaz Rehemtulla

Cancer Res (2014) 74 (19_Supplement): 1137.

https://doi.org/10.1158/1538-7445.AM2014-1137

Published: 01 October 2014

View article titled, Abstract 1137: Bub1 is a key regulator of TGF-β signaling

Journal Articles

Abstract 106: A requirement for FADD and its phosphorylation for KRAS-driven oncogenesis

Brittany M. Bowman, Stefanie Galban, Benjamin A. Hoff, Kevin A. Heist, Jennifer L. Boes, Craig J. Galban, Rajiv M. Patel, Jianke Zhang, Brian D. Ross, Alnawaz Rehemtulla

Cancer Res (2014) 74 (19_Supplement): 106.

https://doi.org/10.1158/1538-7445.AM2014-106

Published: 01 October 2014

View article titled, Abstract 106: A requirement for FADD and its phosphorylation for KRAS-driven oncogenesis

Journal Articles

Abstract 5595: Imaging biomarker development for treatment efficacy for prostate cancer to the bone.

Joshua S. George, Craig J. Galban, Jean-Christophe Brisset, Benjamin Hoff, Stephanie Galban, Alnawaz Rehemtulla, Brian D. Ross

Cancer Res (2013) 73 (8_Supplement): 5595.

https://doi.org/10.1158/1538-7445.AM2013-5595

Published: 15 April 2013

View article titled, Abstract 5595: Imaging biomarker development for treatment efficacy for prostate cancer to the bone.

Journal Articles

Abstract 4433: DW-MR imaging as a predictive biomarker of radiosensitization of GBM through targeted inhibition of checkpoint kinases.

Terence Williams, Stefanie Galbán, Fei Li, Kevin Heist, Craig Galbán, Theodore S. Lawrence, Eric C. Holland, Tami Thomae, Thomas Chenevert, Alnawaz Rehemtulla, Brian D. Ross

Cancer Res (2013) 73 (8_Supplement): 4433.

https://doi.org/10.1158/1538-7445.AM2013-4433

Published: 15 April 2013

View article titled, Abstract 4433: DW-MR imaging as a predictive biomarker of radiosensitization of GBM through targeted inhibition of checkpoint kinases.

Journal Articles

Abstract 2355: Assessment of glioma recurrence following radiotherapy using the parametric response map: A preclinical study

Benjamin Lemasson, Stefanie Galbán, Fei Li, Kevin A. Heist, Judith Sebolt-Leopold, Alnawez Rehemtulla, Thomas Chenevert, Craig Galbán, Brian D. Ross

Cancer Res (2012) 72 (8_Supplement): 2355.

https://doi.org/10.1158/1538-7445.AM2012-2355

Published: 15 April 2012

View article titled, Abstract 2355: Assessment of glioma recurrence following radiotherapy using the parametric response map: A preclinical study

Journal Articles

Abstract 2434: A genetically engineered mouse for imaging of apoptosis in a tissue specific manner

Stefanie Galbán, Yong Hyun Jeon, Lisa M. Sharkey, Benjamin A. Hoff, Craig J. Galban, Brian D. Ross, Alnawaz Rehemtulla

Cancer Res (2012) 72 (8_Supplement): 2434.

https://doi.org/10.1158/1538-7445.AM2012-2434

Published: 15 April 2012

View article titled, Abstract 2434: A genetically engineered mouse for imaging of apoptosis in a tissue specific manner

Journal Articles

Abstract 4299: Evaluation of a new multimodality voxel-based imaging biomarker for therapeutic response assessment in GBM

Benjamin Lemasson, Thomas L. Chenevert, Theodore S. Lawrence, Christina Tsien, Pia C. Sundgren, Charles R. Meyer, Larry Junck, Jennifer Boes, Jean-Christophe Brisset, Stefanie Galbán, Timothy Johnson, Alnawez Rehemtulla, Brian D. Ross, Craig Galbán

Cancer Res (2012) 72 (8_Supplement): 4299.

https://doi.org/10.1158/1538-7445.AM2012-4299

Published: 15 April 2012

View article titled, Abstract 4299: Evaluation of a new multimodality voxel-based imaging biomarker for therapeutic response assessment in GBM

Journal Articles

Abstract 452: Novel MRI-based biomarker for early assessment of glioma recurrence

Benjamin Lemasson, Thomas L. Chenevert, Tom Mikkelsen, Jennifer L. Boes, Timothy D. Johnson, Stefanie Galbán, Alnawez Rehemtulla, Craig Galbán, Brian D. Ross

Cancer Res (2012) 72 (8_Supplement): 452.

https://doi.org/10.1158/1538-7445.AM2012-452

Published: 15 April 2012

View article titled, Abstract 452: Novel MRI-based biomarker for early assessment of glioma recurrence

Journal Articles

Abstract LB-334: Imaging caspase dependent cell death as a surrogate for efficacy of cancer therapeutics

Stefanie Galbán, Michael Lafferty, Lisa M. Sharkey, Katrina A. Schinske, Rahim F. Merchant, Brian D. Ross, A Rehemtulla

Cancer Res (2011) 71 (8_Supplement): LB-334.

https://doi.org/10.1158/1538-7445.AM2011-LB-334

Published: 15 April 2011

View article titled, Abstract LB-334: Imaging caspase dependent cell death as a surrogate for efficacy of cancer therapeutics

Journal Articles

Abstract 2266: Image analysis techniques affect the predictive potential of MRI-based blood volume maps for assessing survival in patients treated for gliomas

Benjamin Lemasson, Stefanie Galbán, Christina Tsien, Charles R. Meyer, Timothy D. Johnson, Thomas L. Chenevert, Alnawaz Alnawaz Rehemtulla, Brian D. Ross, Craig J. Galbán

Cancer Res (2011) 71 (8_Supplement): 2266.

https://doi.org/10.1158/1538-7445.AM2011-2266

Published: 15 April 2011

View article titled, Abstract 2266: Image analysis techniques affect the predictive potential of MRI-based blood volume maps for assessing survival in patients treated for gliomas

Journal Articles

Abstract 5281: Gemcitabine is evaluated as an alternative treatment to temozolomide for high grade gliomas

Stefanie Galbán, Benjamin Lemasson, Terence M. Williams, Fei Li, Kevin Heist, Timothy D. Johnson, Alnawaz Rehemtulla, Craig Galban, Brian D. Ross

Cancer Res (2011) 71 (8_Supplement): 5281.

https://doi.org/10.1158/1538-7445.AM2011-5281

Published: 15 April 2011

View article titled, Abstract 5281: Gemcitabine is evaluated as an alternative treatment to temozolomide for high grade gliomas

Journal Articles

Abstract 5304: A genetically engineered mouse model for GBM wherein Akt kinase activity can be monitored non-invasively in real-time

Stefanie Galbán, Benjamin Lemasson, Michael J. Lafferty, Fei Li, Kevin Heist, Craig J. Galban, Brian D. Ross, Alnawaz Rehemtulla

Cancer Res (2011) 71 (8_Supplement): 5304.

https://doi.org/10.1158/1538-7445.AM2011-5304

Published: 15 April 2011

View article titled, Abstract 5304: A genetically engineered mouse model for GBM wherein Akt kinase activity can be monitored non-invasively in real-time

Journal Articles

Abstract 5090: Targeted inhibition of MEK and AKT pathways in combination with radiation as a novel treatment paradigm in pancreatic cancer

Terence M. Williams, Athena Flecha, Ashwin N. Ram, Paul R. Keller, Stefanie Galban, Craig Galban, Brian D. Ross, Alnawaz Rehemtulla, Judith S. Sebolt-Leopold

Cancer Res (2011) 71 (8_Supplement): 5090.

https://doi.org/10.1158/1538-7445.AM2011-5090

Published: 15 April 2011

View article titled, Abstract 5090: Targeted inhibition of MEK and AKT pathways in combination with radiation as a novel treatment paradigm in pancreatic cancer

Journal Articles

Abstract 1320: Molecular imaging of EMT reveals crosstalk of multiple pathways and provides novel sites for therapeutic intervention of EMT

Shyam Nyati, Mahaveer Swaroop Bhojani, Venkat Keshamouni, Katrina Schinske, Brian D. Ross, Alnawaz Rehemtulla

Cancer Res (2010) 70 (8_Supplement): 1320.

https://doi.org/10.1158/1538-7445.AM10-1320

Published: 15 April 2010

View article titled, Abstract 1320: Molecular imaging of EMT reveals crosstalk of multiple pathways and provides novel sites for therapeutic intervention of EMT

Journal Articles

Abstract 4190: Evaluation of targeted therapy of an experimental glioma model using functional imaging

Stefanie Galban, Craig J. Galban, Dolores Hambardzumyan, Eric C. Holland, Thomas L. Chenevert, Timothy D. Johnson, Omid Saeed-Tehrani, Alnawaz Rehemtulla, Brian D. Ross

Cancer Res (2010) 70 (8_Supplement): 4190.

https://doi.org/10.1158/1538-7445.AM10-4190

Published: 15 April 2010

View article titled, Abstract 4190: Evaluation of targeted therapy of an experimental glioma model using functional imaging

NARROW

Abstract 6366: A novel small molecule inhibitor of MAPK and PI3K ameliorates disease phenotypes in myelofibrosis

Abstract 3936: Orally bioavailable 'lymphatropic' kinase inhibitors

Abstract 2073: Transcriptome profiles of cancer stem-like cells in patient-derived diffuse intrinsic pontine glioma (DIPG)

Abstract 3875: Lymphatically directed MAPK/PI3K/mTOR inhibitor for treatment of cancer growth and metastasis

Abstract 2061: Extended adjuvant temozolomide improves survival in a glioblastoma mouse model

Abstract 1137: Bub1 is a key regulator of TGF-β signaling

Abstract 106: A requirement for FADD and its phosphorylation for KRAS-driven oncogenesis

Abstract 5595: Imaging biomarker development for treatment efficacy for prostate cancer to the bone.

Abstract 4433: DW-MR imaging as a predictive biomarker of radiosensitization of GBM through targeted inhibition of checkpoint kinases.

Abstract 2355: Assessment of glioma recurrence following radiotherapy using the parametric response map: A preclinical study

Abstract 2434: A genetically engineered mouse for imaging of apoptosis in a tissue specific manner

Abstract 4299: Evaluation of a new multimodality voxel-based imaging biomarker for therapeutic response assessment in GBM

Abstract 452: Novel MRI-based biomarker for early assessment of glioma recurrence

Abstract LB-334: Imaging caspase dependent cell death as a surrogate for efficacy of cancer therapeutics

Abstract 2266: Image analysis techniques affect the predictive potential of MRI-based blood volume maps for assessing survival in patients treated for gliomas

Abstract 5281: Gemcitabine is evaluated as an alternative treatment to temozolomide for high grade gliomas

Abstract 5304: A genetically engineered mouse model for GBM wherein Akt kinase activity can be monitored non-invasively in real-time

Abstract 5090: Targeted inhibition of MEK and AKT pathways in combination with radiation as a novel treatment paradigm in pancreatic cancer

Abstract 1320: Molecular imaging of EMT reveals crosstalk of multiple pathways and provides novel sites for therapeutic intervention of EMT

Abstract 4190: Evaluation of targeted therapy of an experimental glioma model using functional imaging

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only